Home › Groups › Pharmacy Learning Network ›

Home

Setting the Standard for Health-System Pharmacist Education

Pharmacy Learning Network (PLN) provides a complete educational experience, specifically targeted to health-system pharmacists. Live regional Pharmacy Learning Network conferences, held nation-wide, offer interactive education in a live setting, followed by sequential web-based programming. This learner-driven, long-term educational method ensures that health-system pharmacists are provided with the knowledge and practical application strategies to implement beneficial changes within their facility.

Ask A PLN Expert!

Have a question on dosages or drug interactions? Facing a challenge and would like the input of a Pharmacy Learning Network faculty member? Click here to ask your question and a Pharmacy Learning Network hospital pharmacy expert will reply!

Ask A Question Now »

Save the Date!

Pharmacy Learning Network provides Health-System Pharmacists with live, local learning across the United States—see our 2012 schedule and mark your calendar!

PHARMACY LEARNING NETWORK 2012 CONFERENCE CALENDAR
 

Each full-day Pharmacy Learning Network conference offers:

New for 2012—PLN Oncology!

Select cities will have the opportunity to attend a half day of education focused solely on oncology pharmacy topics, in conjunction with full-day Pharmacy Learning Network conferences. Read More

Interested in Improving Hemostatic Practices at Your Facility?

In the newest PLN CE Newsletter, Drs. Michael Gabay and Robert MacLaren strategize how to institute optimal hemostatic practices in the surgical setting and increase pharmacy oversight of hemostatic agents.

 

CLICK HERE TO READ MORE

News View More

  • Antidotes to New Anticoagulants Needed for Trauma Setting
    01/27/12
    LAKE BUENA VISTA, FLA. – Patients on one of the powerful new oral anticoagulants are left without a good antidote for bleeding if they experience a traumatic injury. The use of these agents is climbing as baby boomers age and the number of patients with atrial fibrillation continues its steady rise from 2.0 million in 1995 to a projected 4.34 million by 2030. Read More »
  • 2-Year Agalsidase Beta Shortage May Soon End
    01/25/12
    A two-year long shortage of an enzyme replacement therapy for patients with Fabry disease may soon be over, according to its manufacturer. The Genzyme unit of French drugmaker Sanofi said it has received FDA approval to begin producing agalsidase beta (Fabrazyme) at its new manufacturing plant in Framingham, Mass. Read More »
  • PLN Explores Evolution of Health-System Pharmacists
    01/24/12
    More than 92% of attendees of a recent PLN industry webinar indicated that the responsibilities of health-system pharmacists will increase dramatically by 2016, continuing their expansion beyond their outdated role as solely dispensers and monitors of medication use. Read More »